Chief Operating Officer at Turn Biotechnologies.
As Managing Director of the Methuselah Fund, Sergio Ruiz has several years of experience discovering, analyzing, vetting and propelling longevity biotechnologies that can move the needle in the mission to increase the healthy human healthspan. He is also an entrepreneur-investor with a positive hands-on approach to investing who prides himself in helping with the incubation and formation of young academic teams and developing them into successful industry leaders. He currently holds several senior advisory roles for longevity biotechs and is also the Chief Operating Officer for a Stanford-born company called Turn Biotechnologies, focusing on epigenetic resetting of the age in a cell.
Visit website: https://www.lifespan.io/bio/sergio-ruiz
See also: Turn Biotechnologies - Focused on restoring cells’ youthful vigor to repair damage caused by the aging process
Sergio Ruiz is also referenced in the following:
Sergio Ruiz News
Longevity funding innovation prize: shaping the future of longevity research
Live Forever Club - 01-Nov-2023
A $20,000 prize for innovative approaches to increase longevity sector fundingRead more...
Lifespan.io summarises the proceedings of the Buck Institute's Longevity Summit
Lifespan.io (LEAF) - 20-Jan-2023
Another reminder of the amount of research, with multiple approaches, about to go into clinical trialsRead more...